Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Cytometry-based analysis of HLA-G functions according to ILT2 expression.

Jacquier A, Dumont C, Carosella ED, Rouas-Freiss N, LeMaoult J.

Hum Immunol. 2020 Feb 18. pii: S0198-8859(19)31390-4. doi: 10.1016/j.humimm.2020.02.001. [Epub ahead of print]

PMID:
32081570
2.

Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G.

Lombard CA, Sana G, LeMaoult J, Najar M, Ravau J, André F, Bouhtit F, Daouya M, Loustau M, Najimi M, Lagneaux L, Carosella ED, Sokal EM.

J Immunol Res. 2019 Sep 12;2019:8250584. doi: 10.1155/2019/8250584. eCollection 2019.

3.

CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G.

Dumont C, Jacquier A, Verine J, Noel F, Goujon A, Wu CL, Hung TM, Desgrandchamps F, Culine S, Carosella ED, Rouas-Freiss N, LeMaoult J.

Cancer Immunol Res. 2019 Oct;7(10):1619-1632. doi: 10.1158/2326-6066.CIR-18-0764. Epub 2019 Aug 26.

PMID:
31451484
4.

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8+ T cells.

Desgrandchamps F, LeMaoult J, Goujon A, Riviere A, Rivero-Juarez A, Djouadou M, de Gouvello A, Dumont C, Wu CL, Culine S, Verine J, Rouas-Freiss N, Hennequin C, Masson-Lecomte A, Carosella ED.

Oncotarget. 2018 Sep 4;9(69):33160-33169. doi: 10.18632/oncotarget.26036. eCollection 2018 Sep 4.

5.

Extended HLA-G haplotypes in patients with age-related macular degeneration.

Svendsen SG, Nilsson LL, Djurisic S, Funck T, Wu CL, Faber C, Falk MK, Singh A, Sørensen TL, Carosella ED, LeMaoult J, Hviid TVF, Nissen MH.

HLA. 2018 Jul 16. doi: 10.1111/tan.13340. [Epub ahead of print]

PMID:
30009537
6.

The HLA-G Genetic Contribution to Bipolar Disorder: A Trans-Ethnic Replication.

Sundaresh A, Wu CL, Chinnadurai RK, Rajkumar RP, Mariaselvam CM, LeMaoult J, Krishnamoorthy R, Leboyer M, Negi VS, Tamouza R.

Immunol Invest. 2018 Aug;47(6):593-604. doi: 10.1080/08820139.2018.1469649. Epub 2018 May 8.

PMID:
29737889
7.

Correction for Bortolotti et al., "Pseudomonas aeruginosa Quorum Sensing Molecule N-(3-Oxododecanoyl)-l-Homoserine-Lactone Induces HLA-G Expression in Human Immune Cells".

Bortolotti D, LeMaoult J, Trapella C, Di Luca D, Carosella ED, Rizzo R.

Infect Immun. 2017 Nov 17;85(12). pii: e00628-17. doi: 10.1128/IAI.00628-17. Print 2017 Dec. No abstract available.

8.

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.

Rouas-Freiss N, LeMaoult J, Verine J, Tronik-Le Roux D, Culine S, Hennequin C, Desgrandchamps F, Carosella ED.

Oncoimmunology. 2017 Jul 5;6(9):e1342023. doi: 10.1080/2162402X.2017.1342023. eCollection 2017.

9.

Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients.

Tronik-Le Roux D, Renard J, Vérine J, Renault V, Tubacher E, LeMaoult J, Rouas-Freiss N, Deleuze JF, Desgrandschamps F, Carosella ED.

Mol Oncol. 2017 Nov;11(11):1561-1578. doi: 10.1002/1878-0261.12119. Epub 2017 Sep 13.

10.

Expression and differential regulation of HLA-G isoforms in the retinal pigment epithelial cell line, ARPE-19.

Svendsen SG, Udsen MS, Daouya M, Funck T, Wu CL, Carosella ED, LeMaoult J, Hviid TVF, Faber C, Nissen MH.

Hum Immunol. 2017 May - Jun;78(5-6):414-420. doi: 10.1016/j.humimm.2017.04.007. Epub 2017 Apr 22.

PMID:
28442288
11.

The role of methylation, DNA polymorphisms and microRNAs on HLA-G expression in human embryonic stem cells.

Verloes A, Spits C, Vercammen M, Geens M, LeMaoult J, Sermon K, Coucke W, Van de Velde H.

Stem Cell Res. 2017 Mar;19:118-127. doi: 10.1016/j.scr.2017.01.005. Epub 2017 Jan 9.

12.

Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation.

von Websky MW, Kitamura K, Ludwig-Portugall I, Kurts C, von Laffert M, LeMaoult J, Carosella ED, Abu-Elmagd K, Kalff JC, Schäfer N.

PLoS One. 2016 Jul 12;11(7):e0158907. doi: 10.1371/journal.pone.0158907. eCollection 2016.

13.

Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4.

Wu CL, Svendsen SG, Riviere A, Desgrandchamps F, Carosella ED, LeMaoult J.

Hum Immunol. 2016 Sep;77(9):720-6. doi: 10.1016/j.humimm.2016.01.017. Epub 2016 Feb 10.

PMID:
26874236
14.

Pseudomonas aeruginosa Quorum Sensing Molecule N-(3-Oxododecanoyl)-L-Homoserine-Lactone Induces HLA-G Expression in Human Immune Cells.

Bortolotti D, LeMaoult J, Trapella C, Di Luca D, Carosella ED, Rizzo R.

Infect Immun. 2015 Oct;83(10):3918-25. doi: 10.1128/IAI.00803-15. Epub 2015 Jul 20. Erratum in: Infect Immun. 2017 Nov 17;85(12 ):.

15.

HLA-G: An Immune Checkpoint Molecule.

Carosella ED, Rouas-Freiss N, Tronik-Le Roux D, Moreau P, LeMaoult J.

Adv Immunol. 2015;127:33-144. doi: 10.1016/bs.ai.2015.04.001. Epub 2015 May 27. Review.

PMID:
26073983
16.

Trogocytic intercellular membrane exchanges among hematological tumors.

LeMaoult J, Caumartin J, Daouya M, Switala M, Rebmann V, Arnulf B, Carosella ED.

J Hematol Oncol. 2015 Mar 14;8:24. doi: 10.1186/s13045-015-0114-8.

17.

A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.

Carosella ED, Ploussard G, LeMaoult J, Desgrandchamps F.

Eur Urol. 2015 Aug;68(2):267-79. doi: 10.1016/j.eururo.2015.02.032. Epub 2015 Mar 29. Review.

PMID:
25824720
18.

HLA-G expression levels influence the tolerogenic activity of human DC-10.

Amodio G, Comi M, Tomasoni D, Gianolini ME, Rizzo R, LeMaoult J, Roncarolo MG, Gregori S.

Haematologica. 2015 Apr;100(4):548-57. doi: 10.3324/haematol.2014.113803. Epub 2015 Feb 6.

19.

The dual role of HLA-G in cancer.

Rouas-Freiss N, Moreau P, LeMaoult J, Carosella ED.

J Immunol Res. 2014;2014:359748. doi: 10.1155/2014/359748. Epub 2014 Mar 31. Review.

20.

Synthetic HLA-G proteins for therapeutic use in transplantation.

LeMaoult J, Daouya M, Wu J, Loustau M, Horuzsko A, Carosella ED.

FASEB J. 2013 Sep;27(9):3643-51. doi: 10.1096/fj.13-228247. Epub 2013 Jun 10.

21.

In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes.

Alegre E, Rebmann V, Lemaoult J, Rodriguez C, Horn PA, Díaz-Lagares A, Echeveste JI, González A.

Eur J Immunol. 2013 Jul;43(7):1933-9. doi: 10.1002/eji.201343318. Epub 2013 May 17.

22.

Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors.

HoWangYin KY, Loustau M, Wu J, Alegre E, Daouya M, Caumartin J, Sousa S, Horuzsko A, Carosella ED, LeMaoult J.

Cell Mol Life Sci. 2012 Dec;69(23):4041-9. doi: 10.1007/s00018-012-1069-3. Epub 2012 Jul 17.

23.

The immunosuppressive molecule HLA-G and its clinical implications.

González A, Rebmann V, LeMaoult J, Horn PA, Carosella ED, Alegre E.

Crit Rev Clin Lab Sci. 2012 May-Jun;49(3):63-84. doi: 10.3109/10408363.2012.677947. Epub 2012 Apr 26. Review.

PMID:
22537084
24.

HLA-G inhibition of NK-cell cytolytic function is uncoupled from tumor cell lipid raft reorganization.

Baudhuin J, Lesport E, Sousa S, Migraine J, Vigneron J, Lemaoult J, Carosella ED, Mooney N, Favier B.

Eur J Immunol. 2012 Mar;42(3):700-9. doi: 10.1002/eji.201141930. Epub 2012 Jan 19.

25.

The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells.

Carosella ED, Gregori S, LeMaoult J.

Blood. 2011 Dec 15;118(25):6499-505. doi: 10.1182/blood-2011-07-370742. Epub 2011 Sep 29. Review.

PMID:
21960588
26.

Tolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivo.

Favier B, HoWangYin KY, Wu J, Caumartin J, Daouya M, Horuzsko A, Carosella ED, LeMaoult J.

PLoS One. 2011;6(7):e21011. doi: 10.1371/journal.pone.0021011. Epub 2011 Jul 14.

27.

Identification of circulating nonclassic human leukocyte antigen G (HLA-G)-like molecules in exudates.

Gonzalez A, Alegre E, Arroyo A, LeMaoult J, Echeveste JI.

Clin Chem. 2011 Jul;57(7):1013-22. doi: 10.1373/clinchem.2010.159673. Epub 2011 Apr 28.

PMID:
21527645
28.

Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.

Lesport E, Baudhuin J, Sousa S, LeMaoult J, Zamborlini A, Rouas-Freiss N, Carosella ED, Favier B.

Cell Mol Life Sci. 2011 Oct;68(20):3385-99. doi: 10.1007/s00018-011-0632-7. Epub 2011 Feb 20. Erratum in: Cell Mol Life Sci. 2011 Oct;68(20):3401.

PMID:
21337044
29.

HLA-G expression in human embryonic stem cells and preimplantation embryos.

Verloes A, Van de Velde H, LeMaoult J, Mateizel I, Cauffman G, Horn PA, Carosella ED, Devroey P, De Waele M, Rebmann V, Vercammen M.

J Immunol. 2011 Feb 15;186(4):2663-71. doi: 10.4049/jimmunol.1001081. Epub 2011 Jan 19.

30.

Proper regrafting of Ig-like transcript 2 after trogocytosis allows a functional cell-cell transfer of sensitivity.

HoWangYin KY, Caumartin J, Favier B, Daouya M, Yaghi L, Carosella ED, LeMaoult J.

J Immunol. 2011 Feb 15;186(4):2210-8. doi: 10.4049/jimmunol.1000547. Epub 2011 Jan 17.

31.

The role of HLA-G in immunity and hematopoiesis.

Carosella ED, Gregori S, Rouas-Freiss N, LeMaoult J, Menier C, Favier B.

Cell Mol Life Sci. 2011 Feb;68(3):353-68. doi: 10.1007/s00018-010-0579-0. Epub 2010 Nov 30. Review.

PMID:
21116680
32.

HLA-G: a look back, a look forward.

Carosella ED, LeMaoult J.

Cell Mol Life Sci. 2011 Feb;68(3):337-40. doi: 10.1007/s00018-010-0577-2. Epub 2010 Nov 19. Review. No abstract available.

PMID:
21088981
33.

Membrane redistributions through multi-intercellular exchanges and serial trogocytosis.

Alegre E, Howangyin KY, Favier B, Baudhuin J, Lesport E, Daouya M, Gonzalez A, Carosella ED, Lemaoult J.

Cell Res. 2010 Nov;20(11):1239-51. doi: 10.1038/cr.2010.136. Epub 2010 Sep 28.

PMID:
20877312
34.

Different functional outcomes of intercellular membrane transfers to monocytes and T cells.

HoWangYin KY, Alegre E, Daouya M, Favier B, Carosella ED, LeMaoult J.

Cell Mol Life Sci. 2010 Apr;67(7):1133-45.

PMID:
20238479
35.

Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule.

Menier C, Rouas-Freiss N, Favier B, LeMaoult J, Moreau P, Carosella ED.

Tissue Antigens. 2010 Mar;75(3):201-6. doi: 10.1111/j.1399-0039.2009.01438.x. Epub 2009 Dec 30. Review.

PMID:
20047640
36.

ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.

Favier B, Lemaoult J, Lesport E, Carosella ED.

FASEB J. 2010 Mar;24(3):689-99. doi: 10.1096/fj.09-135194. Epub 2009 Oct 19.

PMID:
19841038
37.

Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell.

Lesport E, Baudhuin J, LeMaoult J, Sousa S, Doliger C, Carosella ED, Favier B.

Hum Immunol. 2009 Dec;70(12):1000-5. doi: 10.1016/j.humimm.2009.07.019. Epub 2009 Aug 3.

PMID:
19654030
38.

HLA-G-dependent suppressor cells: Diverse by nature, function, and significance.

Carosella ED, HoWangYin KY, Favier B, LeMaoult J.

Hum Immunol. 2008 Nov;69(11):700-7. doi: 10.1016/j.humimm.2008.08.280. Epub 2008 Sep 24. Review.

PMID:
18817832
39.

Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu.

Díaz-Lagares A, Alegre E, LeMaoult J, Carosella ED, González A.

Immunology. 2009 Mar;126(3):436-45. doi: 10.1111/j.1365-2567.2008.02911.x. Epub 2008 Sep 1.

40.

Beyond the increasing complexity of the immunomodulatory HLA-G molecule.

Carosella ED, Favier B, Rouas-Freiss N, Moreau P, Lemaoult J.

Blood. 2008 May 15;111(10):4862-70. doi: 10.1182/blood-2007-12-127662. Epub 2008 Mar 11. Review.

PMID:
18334671
41.

HLA-G: from biology to clinical benefits.

Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N.

Trends Immunol. 2008 Mar;29(3):125-32. doi: 10.1016/j.it.2007.11.005. Epub 2008 Feb 4. Review.

PMID:
18249584
42.

Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.

Rouas-Freiss N, Moreau P, Menier C, LeMaoult J, Carosella ED.

Semin Cancer Biol. 2007 Dec;17(6):413-21. Epub 2007 Jul 17. Review.

PMID:
17881247
43.

CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.

Naji A, Le Rond S, Durrbach A, Krawice-Radanne I, Creput C, Daouya M, Caumartin J, LeMaoult J, Carosella ED, Rouas-Freiss N.

Blood. 2007 Dec 1;110(12):3936-48. Epub 2007 Sep 5.

PMID:
17804694
44.

Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy.

Alegre E, Díaz-Lagares A, Lemaoult J, López-Moratalla N, Carosella ED, González A.

Hum Immunol. 2007 Aug;68(8):661-7. Epub 2007 May 25.

PMID:
17678720
45.

Research on HLA-G: an update.

Favier B, LeMaoult J, Rouas-Freiss N, Moreau P, Menier C, Carosella ED.

Tissue Antigens. 2007 Mar;69(3):207-11. Review.

PMID:
17493143
46.

Functions of HLA-G in the immune system.

Favier B, LeMaoult J, Carosella ED.

Tissue Antigens. 2007 Apr;69 Suppl 1:150-2. Review.

PMID:
17445191
47.

Quantification and identification of soluble HLA-G isoforms.

Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H.

Tissue Antigens. 2007 Apr;69 Suppl 1:143-9.

PMID:
17445190
48.

Exchanges of membrane patches (trogocytosis) split theoretical and actual functions of immune cells.

LeMaoult J, Caumartin J, Carosella ED.

Hum Immunol. 2007 Apr;68(4):240-3. Epub 2006 Dec 22. Review.

PMID:
17400058
49.

Trogocytosis-based generation of suppressive NK cells.

Caumartin J, Favier B, Daouya M, Guillard C, Moreau P, Carosella ED, LeMaoult J.

EMBO J. 2007 Mar 7;26(5):1423-33. Epub 2007 Feb 22.

50.

Intercellular exchanges of membrane patches (trogocytosis) highlight the next level of immune plasticity.

Caumartin J, Lemaoult J, Carosella ED.

Transpl Immunol. 2006 Dec;17(1):20-2. Epub 2006 Oct 16. Review.

PMID:
17157208

Supplemental Content

Loading ...
Support Center